(Q35977062)

English

Intravenous immunoglobulin treatment for fibrosis, atherosclerosis, and malignant conditions.

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15585934

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585934%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

review article

1 reference

stated in

Europe PubMed Central

title

Intravenous immunoglobulin treatment for fibrosis, atherosclerosis, and malignant conditions (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15585934

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585934%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

2

Yehuda Shoenfeld

2 references

stated in

Europe PubMed Central

PubMed publication ID

15585934

retrieved

11 August 2017

stated in

Europe PubMed Central

PubMed publication ID

15585934

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585934%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1

Ilan Krause

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11 August 2017

Ilan Krause

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15585934

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585934%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

publication date

1 January 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15585934

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585934%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

published in

Methods in Molecular Medicine

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15585934

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585934%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

volume

109

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15585934

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585934%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

page(s)

403-408

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15585934

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585934%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

Identifiers

DOI

10.1385/1-59259-862-5:403

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15585934

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585934%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 January 2020

PubMed publication ID

15585934

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15585934

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15585934%20AND%20SRC:MED&resulttype=core&format=json

(Q35977062)

Intravenous immunoglobulin treatment for fibrosis, atherosclerosis, and malignant conditions.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)